These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 17970887)

  • 1. Methotrexate in dermatology.
    Bangert CA; Costner MI
    Dermatol Ther; 2007; 20(4):216-28. PubMed ID: 17970887
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The use of methotrexate in dermatology: a review.
    Shen S; O'Brien T; Yap LM; Prince HM; McCormack CJ
    Australas J Dermatol; 2012 Feb; 53(1):1-18. PubMed ID: 22309324
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methotrexate: mechanism of action, pharmacokinetics, clinical indications, and toxicity.
    Grosflam J; Weinblatt ME
    Curr Opin Rheumatol; 1991 Jun; 3(3):363-8. PubMed ID: 1883690
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Understanding the mechanisms of action of methotrexate: implications for the treatment of rheumatoid arthritis.
    Tian H; Cronstein BN
    Bull NYU Hosp Jt Dis; 2007; 65(3):168-73. PubMed ID: 17922664
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravenous immunoglobulin: properties, mode of action and practical use in dermatology.
    Prins C; Gelfand EW; French LE
    Acta Derm Venereol; 2007; 87(3):206-18. PubMed ID: 17533485
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Update on the dermatologic use of systemic glucocorticosteroids.
    Jackson S; Gilchrist H; Nesbitt LT
    Dermatol Ther; 2007; 20(4):187-205. PubMed ID: 17970885
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Azathioprine in dermatology: the past, the present, and the future.
    Patel AA; Swerlick RA; McCall CO
    J Am Acad Dermatol; 2006 Sep; 55(3):369-89. PubMed ID: 16908341
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methotrexate: new mechanisms and old toxicities.
    Furst DE
    Agents Actions Suppl; 1993; 44():131-7. PubMed ID: 8396846
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Methotrexate in dermatology: current aspects].
    Plantin P; Saraux A; Guillet G
    Ann Dermatol Venereol; 1989; 116(2):109-15. PubMed ID: 2660705
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Methotrexate in dermatology: pharmacology, indications, applications and prudent use].
    Lebrun-Vignes B; Bachelez H; Chosidow O
    Rev Med Interne; 1999 Aug; 20 Suppl 3():384s-392s. PubMed ID: 10480190
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Side effects of methotrexate in the treatment of skin diseases].
    Ruszczak Z; Prószyńska-Kuczyńska W; Krajewski C
    Wiad Lek; 1974 Jun; 27(12):1083-6. PubMed ID: 4600611
    [No Abstract]   [Full Text] [Related]  

  • 12. Adverse drug interactions clinically important for the dermatologist.
    Andersen WK; Feingold DS
    Arch Dermatol; 1995 Apr; 131(4):468-73. PubMed ID: 7726592
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methotrexate: role of treatment in skin disease.
    Holliday AC; Moody MN; Berlingeri-Ramos A
    Skin Therapy Lett; 2013; 18(3):4-9. PubMed ID: 23674145
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effective treatment of recurrent keratoacanthoma using methotrexate].
    Schoon-Blaauw GH; Berretty PJ; Ideler AH; Tan-Go I
    Ned Tijdschr Geneeskd; 1994 Feb; 138(8):410-3. PubMed ID: 8127383
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methotrexate: prescribing and monitoring practices among the consultant membership of the British Association of Dermatologists.
    Collin B; Srinathan SK; Finch TM
    Br J Dermatol; 2008 Apr; 158(4):793-800. PubMed ID: 18241256
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Complications in the course of treatment of skin diseases with methotrexate].
    Ruszczak Z; Prózyńska-Kuczyńska W; Bienias L; Bednarowicz G
    Przegl Dermatol; 1974; 61(5):619-22. PubMed ID: 4423443
    [No Abstract]   [Full Text] [Related]  

  • 17. Azathioprine: a guide for the management of dermatology patients.
    Wise M; Callen JP
    Dermatol Ther; 2007; 20(4):206-15. PubMed ID: 17970886
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dapsone and sulfones in dermatology: overview and update.
    Zhu YI; Stiller MJ
    J Am Acad Dermatol; 2001 Sep; 45(3):420-34. PubMed ID: 11511841
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advances in individual prediction of methotrexate toxicity: a review.
    Schmiegelow K
    Br J Haematol; 2009 Sep; 146(5):489-503. PubMed ID: 19538530
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Oral contraceptives in dermatology].
    Sancho B; Guerra-Tapia A
    Actas Dermosifiliogr; 2009; 100(6):445-55. PubMed ID: 19709548
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.